Rodin Therapeutics
Founded
2013
2013
Geography
United States of America based
United States of America based
Funding
$57.200 M
$57.200 M
Rodin Therapeutics, a biotechnology company applying insights of epigenetics to novel therapeutics for neurological disorders, announced its founding by Atlas Venture and Proteros biostructures. Rodin is founded based on its insight into key epigenetic modulators of CNS function, privileged access to Proteros' best-in-class structural biology capabilities, and a team with deep CNS drug development and company formation experience. Rodin secured financing from Atlas Venture and Johnson & Johnson Development Corporation (JJDC).
Technologies
Epigenetics StartupsR&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet